Preliminary PDUFA IV Financial Baseline and Enhancements (Starting in FY 2008)
You may also be interested in...
User Fees To Rise By 11 Percent For Drug Applications In Fiscal 2010
FDA to collect $1.4 million for each application requiring clinical data; total of $569 million in fees for applications, establishments and products.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials